Search the catalogued universe, read what our research actually found, and see an indicative price wherever a real third-party quote exists.
Shown for discovery. Not a recommendation, and not an executable quote.
Explore full marketPrices shown are indicative — derived from the latest sourced third-party quote, never an executable market quote. Presence in this market is not a recommendation.
See the unlisted market journeyThe private-market names investors most often ask us about, gathered in one place so you do not have to search for them. This is a discovery shelf, not a ranking and not a recommendation: featuring a company says nothing about whether Prospera rates it. Research depth and any published Prospera view are shown on each card exactly as they stand, and several of these carry no sourced quote at all — where that is the case the card says so rather than showing an estimate.
3 of 11 carry a current sourced quote · the rest say “price unavailable”
How pricing works here. Prospera Indicative Price = latest sourced quote x 0.99. The underlying source quote is preserved unchanged and shown alongside. An indicative reference derived from the latest third-party source quote — not an executable, firm or guaranteed price. Actual transaction pricing is confirmed only at the time of a specific deal. 6 of 83 companies currently have a sourced quote on record; the rest read “Not available” rather than an estimate. Price lines are drawn only from real dated observations — 6 companies have enough of them to chart.
Financials, valuation, peer comparison and the full Prospera Private Market Score have been independently researched — and every one of these carries a published Prospera view and a sourced indicative price. Depth of work, not a recommendation: at least one of these conclusions is negative.
Every company here has at least one dated third-party quote on record, so a Prospera Indicative Price can be derived from it. It is not a ranking, and an indicative price is not an executable quote.
Recorded corporate status only: a DRHP has been filed, or the company is formally in a pre-IPO process. Filing is not a listing, and timelines slip.
There is no “Popular”, “Most viewed”, “Trending” or “Recently added” section, because we do not record the data those labels would claim: no view counts, no watchlist or enquiry volumes, and no reliable date on which a company entered coverage. There are no gainers or losers either — private-market quotes are irregular, sparse and drawn from different sources, so a percentage move between two of them is not a return. Every section above is a filter over facts we can point at.
The catalogued universe grouped by the sector each company actually operates in. Every one of these 18 sectors contains at least one researched company. Each tile shows coverage — how many companies we hold and how much work stands behind them — never a sector average, a sector return or a “hot sector” signal, none of which this data can support.
The complete catalogued universe — search it, filter it by research depth, corporate status, sector or whether a sourced price exists, and sort it. Presence here is never, on its own, a recommendation.
Showing 24 of 83 companies
A good company can still be an expensive investment. And a low share price does not automatically mean a cheap one. Prospera researches the whole chain — not just the first link.
Every company on Prospera Unlisted Markets is researched through as much of this chain as the evidence allows — and we tell you exactly how far that research has gone.
Private markets are opaque by construction. The remedy is not louder promises; it is publishing the method, the sources and the limits.
Explore the companies. Understand the business. Study the evidence. Then decide whether the opportunity belongs in your portfolio.